Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innovate (VATE) EBT (2016 - 2025)

Historic EBT for Innovate (VATE) over the last 17 years, with Q3 2025 value amounting to -$16.7 million.

  • Innovate's EBT fell 2748.09% to -$16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$67.1 million, marking a year-over-year decrease of 14136.69%. This contributed to the annual value of -$33.4 million for FY2024, which is 290.7% up from last year.
  • Latest data reveals that Innovate reported EBT of -$16.7 million as of Q3 2025, which was down 2748.09% from -$16.8 million recorded in Q2 2025.
  • Over the past 5 years, Innovate's EBT peaked at $11.4 million during Q2 2024, and registered a low of -$41.8 million during Q1 2021.
  • Its 5-year average for EBT is -$12.7 million, with a median of -$12.5 million in 2022.
  • Per our database at Business Quant, Innovate's EBT soared by 20857.14% in 2024 and then crashed by 24736.84% in 2025.
  • Innovate's EBT (Quarter) stood at -$3.7 million in 2021, then plummeted by 116.22% to -$8.0 million in 2022, then decreased by 16.25% to -$9.3 million in 2023, then tumbled by 60.22% to -$14.9 million in 2024, then decreased by 12.08% to -$16.7 million in 2025.
  • Its EBT stands at -$16.7 million for Q3 2025, versus -$16.8 million for Q2 2025 and -$18.7 million for Q1 2025.